Figure 3. Gene targets that are predicted to reduce the AFR and their association with prognostic markers of breast cancer patients.

1. A schematic representation of the 12 predicted gene targets, marked in red.
2. Ten predicted targets that show a significantly higher expression in metastatic versus non-metastatic tumor samples (n = 295).
3. Nine predicted targets that show a significantly higher expression in grade 3 versus grade 1 tumor samples (n = 236).
4. Nine predicted targets whose lower expression is significantly associated with improved long-term survival (n = 1568).